SCHEMBL8440303

SCHEMBL8440303

COc1ccc(C[S+]([O-])C2CC(=O)N2CC(=O)CCc2ccccc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.45
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
F2RL1 P55085 1/20 0.43
PLAAT3 P53816 2/20 0.43
PLAAT5 Q96KN8 2/20 0.43
PLAAT2 Q9NWW9 2/20 0.43
PLAAT4 Q9UL19 2/20 0.43
ALDH1A1 P00352 6/20 0.41
ALOX5 P09917 2/20 0.40
POLB P06746 2/20 0.40
CASP3 P42574 1/20 0.40
CASP7 P55210 1/20 0.40
GAA P10253 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MAPT P10636 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HSD17B10 Q99714 1/20 0.39
HCRTR1 O43613 1/20 0.39
HCRTR2 O43614 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8772387 0.91 HMOX1 (0.40) NPC1ALDH1A1POLBTDP1L3MBTL1
SCHEMBL8772456 0.87 NPC1 (0.44) TP53NPC1RAB9AF2RL1PLAAT3
SCHEMBL8772512 0.87 PLAAT3 (0.40) NPC1PLAAT3PLAAT5PLAAT2PLAAT4
SCHEMBL8772514 0.85 HCRTR1 (0.41) ALOX5POLBGAAHCRTR1HCRTR2
SCHEMBL8772447 0.82 LMNA (0.45) TP53NPC1RAB9APLAAT3PLAAT5
SCHEMBL8772384 0.82 MAPT (0.42) ALOX5MAPT
SCHEMBL8443669 0.82 HMOX1 (0.40) NPC1ALDH1A1POLBGAATDP1
SCHEMBL8102560 0.81 HMOX1 (0.40) NPC1ALDH1A1ALOX5POLBTDP1
SCHEMBL8772457 0.80 RAB9A (0.42) TP53NPC1RAB9AALDH1A1ALOX5
SCHEMBL8104046 0.80 HMOX1 (0.38) NPC1ALDH1A1POLBGAATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0799200-A1 SUBSTITUTED AZETIDIN-2-ONES FOR TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-10-08 EP claimed
US-5990102-A Substituted azetidin-2-ones for treatment of atherosclerosis SMITHKLINE BEECHAM P.L.C. (GB) 1999-11-23 US disclosed